Donor Natural Killer Cell Infusion, Rituximab, Aldesleukin, and Chemotherapy in Treating Patients With Relapsed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia
This study is currently recruiting participants.
Study NCT00625729
Information provided by National Cancer Institute (NCI)
First Received: February 26, 2008
Last Updated: October 7, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
